CRAIGAVON-headquartered pharma firm Almac has reported a 6 per cent increase in turnover from £634.3 million to £677.3 million in its financial year to September 2020. That hike led to improved ...

LOWER SALFORD — New jobs are one of the focuses of business development efforts, but the number of jobs that are maintained is also important, Pennsylvania Department of Community and Economic ...

Almac, a U.K.-based CDMO, snagged a $200,000 grant from the Bill and Melinda Gates Foundation to support a project aimed at reducing the costs of ingredients used to manufacture contraceptives. The ...

Almac has announced that it has signed an exclusive global distribution deal with Affymetrix, Inc. enabling them to directly sell Almac’s proprietary Xcel™ array for biomarker discovery, development ...

LOWER SALFORD – Almac Group, the global contract pharmaceutical development and manufacturing organization, is proud to announce the organization’s participation in MFG Day 2019. Almac hosted more ...

LOWER SALFORD — A major expansion is underway for the Almac Group at its North American headquarters in Lower Salford. The pharmaceutical development and manufacturing company hosted a ceremonial ...

ALMAC, a corporation specializing in aluminum parts for electric vehicles, announced on the 30th that it has signed a parts supply contract worth 190 billion won with a global automobile manufacturer ...

SOUDERTON, Pennsylvania, September 8, 2010 /PRNewswire/ -- Almac (http://www.almacgroup.com/) announced today that it has officially gained full possession of both ...

PARSIPPANY, N.J., -- DSM Pharmaceutical Products, the custom manufacturing and technology business of Royal DSM (NYSE, Euronext: DSM KON), announced today that it has signed a collaboration agreement ...

Almac and VTU Technology have announced their collaboration to offer joint services for the expression of recombinant proteins with site-specific modification and labelling, such as PEGylation for ...

Presentations highlight significant new data for key oncology drug development programmes - USP7 small molecule inhibitors and ROR1 Protein: Drug Conjugates "We have developed ADP-c165, a potent and ...